Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Key: Camargo Pharmaceutical Services (0) Acquired (1)
cantharidin (Ycanth) (5 trials)
99mtc ecdg (2 trials)
fludeoxyglucose f-18 (2 trials)
tetracycline (tetrex) (1 trial)
99mtc ethylenedicysteine-deoxyglucose (1 trial)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Trials (8 total)
Trial APIs (5 total)